4.7 Letter

Letter: Hepatitis B and MAFLD - a consilience of risk factors for hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B

Mandana Khalili et al.

Summary: In a large North American cohort of chronic hepatitis B patients, nearly a third had fatty liver disease, with 13% having steatohepatitis. Steatohepatitis was associated with advanced fibrosis and increased hepatic inflammation markers over time, highlighting the importance of screening and managing metabolic abnormalities to prevent disease progression in HBV patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Editorial Material Gastroenterology & Hepatology

Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy

Terry Cheuk-Fung Yip et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Gastroenterology & Hepatology

Modelling NAFLD disease burden in four Asian regions-2019-2030

Chris Estes et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Gastroenterology & Hepatology

Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Ting Ting Chan et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Editorial Material Gastroenterology & Hepatology

When a new definition overhauls perceptions of MAFLD related cirrhosis care

Kenneth I. Zheng et al.

HEPATOBILIARY SURGERY AND NUTRITION (2020)